Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide
To evalute the safety and efficacy in reducing Cytokine Release Syndrome after hematopoietic stem cell transplantation by introducing immunosuppression earlier…
Hematologic Disease and DisordersHematopoietic Cell Transplant
Estimated
~$10 – $6,250
Northside Hospital, Inc.NCT06828796
Phase 1
A Phase 1 Study to Evaluate the Safety of KLN-1010, a Novel, In Vivo Gene Therapy to Generate Anti-B Cell Maturation Antigen (Anti-BCMA) Chimeric Antigen Receptor-T Cells (CAR-T) in Patients With Relapsed and Refractory Multiple Myeloma
The goal of this clinical trial is to evaluate the safety, tolerability, and recommended Phase 2 Dose (RP2D) of KLN-1010 in patients with relapsed or refractor…
Multiple Myeloma in RelapseMyeloma MultipleMultiple Myeloma Progression+11 more
Estimated
~$10 – $8,750
Kelonia Therapeutics, Inc.NCT07075185